Colombo F - Search Results

1

Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.

Bjaanaes MM, Halvorsen AR, Solberg S, Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M, Pastorino U, Kure E, Børresen-Dale AL, Brustugun OT, Helland A. Bjaanaes MM, et al. Among authors: colombo f. Int J Cancer. 2014 Oct 15;135(8):1812-21. doi: 10.1002/ijc.28828. Epub 2014 Mar 14. Int J Cancer. 2014. PMID: 24599520 Free PMC article.

2

N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers.

Spinola M, Colombo F, Falvella FS, Dragani TA. Spinola M, et al. Among authors: colombo f. Int J Cancer. 2007 Jun 15;120(12):2744-8. doi: 10.1002/ijc.22601. Int J Cancer. 2007. PMID: 17304507 Free article.

3

BHLHB3: a candidate tumor suppressor in lung cancer.

Falvella FS, Colombo F, Spinola M, Campiglio M, Pastorino U, Dragani TA. Falvella FS, et al. Among authors: colombo f. Oncogene. 2008 Jun 12;27(26):3761-4. doi: 10.1038/sj.onc.1211038. Epub 2008 Jan 28. Oncogene. 2008. PMID: 18223678

4

Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine.

Colombo F, Falvella FS, De Cecco L, Tortoreto M, Pratesi G, Ciuffreda P, Ottria R, Santaniello E, Cicatiello L, Weisz A, Dragani TA. Colombo F, et al. Int J Cancer. 2009 May 1;124(9):2179-85. doi: 10.1002/ijc.24168. Int J Cancer. 2009. PMID: 19123479 Free article.

5

Transcriptome of normal lung distinguishes mouse lines with different susceptibility to inflammation and to lung tumorigenesis.

Franco MD, Colombo F, Galvan A, Cecco LD, Spada E, Milani S, Ibanez OM, Dragani TA. Franco MD, et al. Among authors: colombo f. Cancer Lett. 2010 Aug 28;294(2):187-94. doi: 10.1016/j.canlet.2010.01.038. Epub 2010 Mar 1. Cancer Lett. 2010. PMID: 20189714

6

MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment.

Spinola M, Falvella FS, Colombo F, Sullivan JP, Shames DS, Girard L, Spessotto P, Minna JD, Dragani TA. Spinola M, et al. Among authors: colombo f. Mol Cancer. 2010 Mar 17;9:62. doi: 10.1186/1476-4598-9-62. Mol Cancer. 2010. PMID: 20236515 Free PMC article.

7

Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5.

Falvella FS, Galvan A, Colombo F, Frullanti E, Pastorino U, Dragani TA. Falvella FS, et al. Among authors: colombo f. J Natl Cancer Inst. 2010 Sep 8;102(17):1366-70. doi: 10.1093/jnci/djq264. Epub 2010 Aug 23. J Natl Cancer Inst. 2010. PMID: 20733116

8

Multiple genetic loci modulate lung adenocarcinoma clinical staging.

Frullanti E, Galvan A, Falvella FS, Manenti G, Colombo F, Vannelli A, Incarbone M, Alloisio M, Nosotti M, Santambrogio L, Gonzalez-Neira A, Pastorino U, Dragani TA. Frullanti E, et al. Among authors: colombo f. Clin Cancer Res. 2011 Apr 15;17(8):2410-6. doi: 10.1158/1078-0432.CCR-10-2394. Epub 2011 Jan 17. Clin Cancer Res. 2011. PMID: 21242121

9

A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Colombo F, Falvella FS, Galvan A, Frullanti E, Kunitoh H, Ushijima T, Dragani TA. Colombo F, et al. Mol Cancer. 2011 Jul 7;10:81. doi: 10.1186/1476-4598-10-81. Mol Cancer. 2011. PMID: 21736709 Free PMC article.

10

Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue.

Frullanti E, Colombo F, Falvella FS, Galvan A, Noci S, De Cecco L, Incarbone M, Alloisio M, Santambrogio L, Nosotti M, Tosi D, Pastorino U, Dragani TA. Frullanti E, et al. Among authors: colombo f. Int J Cancer. 2012 Sep 1;131(5):E643-8. doi: 10.1002/ijc.27426. Epub 2012 Feb 28. Int J Cancer. 2012. PMID: 22223368 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

999 results

Search Page